ArticleAllergy2013

A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.

R A Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.